Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 4 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Results 1 - 20 of 37 : 1 2 Next »

Recs

0
Member Avatar valuemoneygreen (80.64) Submitted: 6/5/2014 2:04:41 PM : Outperform Start Price: $25.53 BRLI Score: +4.62

The 32% short side of the float ran into some problems today.

Recs

0
Member Avatar MWillou (32.73) Submitted: 12/20/2013 9:30:14 AM : Outperform Start Price: $25.20 BRLI Score: +4.19

Near-term ACA pressure will negatively impact BRLI and the other healthcare provider (health system, clinical labs) companies. Several years out, I expect BRLI to increase because it performs esoteric tests that DGX and LH do not. Game changer in lab industry is Theranos, who is not doing esoteric testing right now.

Recs

0
Member Avatar GVFool15 (61.55) Submitted: 12/19/2013 11:35:30 PM : Underperform Start Price: $25.20 BRLI Score: -4.19

New healthcare laws are changing the industry, providing slower growth rates for companies like BRLI.

Recs

0
Member Avatar 10x2 (25.99) Submitted: 10/3/2013 6:53:41 PM : Outperform Start Price: $29.07 BRLI Score: -19.72

Revenues and earnings growth have accelerated while the PE has contracted. This, as a value minded guy, is a good thing so long as the earnings don't fall off the chart. The analysts think they will grow at 17% going forward. Hopefully I can pick up more shares next year on the cheap. This company has virtually 0 debt. I like them a lot and expect to hold them a long time.

Long BRLI

Recs

0
Member Avatar tecramer (< 20) Submitted: 9/2/2013 8:33:18 PM : Outperform Start Price: $29.29 BRLI Score: -22.29

This small player has lots of room to grow with some innovative tests and interesting acquisitions that should help expand market share along with geographic coverage.

Recs

0
Member Avatar reeshau (47.33) Submitted: 4/26/2013 10:32:37 AM : Outperform Start Price: $24.90 BRLI Score: -10.25

BRLI has a history of steady growth, a dominant role in two niche markets: prisons (nationwide) and the NYC area. And continued attention from two short seller / publishers has driven the short position to 42% of the float. The chances of this going to zero are slim. The chances of the publishers being the first shorts out, ahead of a stampede to close, are great.

Recs

0
Member Avatar cheezyches (95.51) Submitted: 4/16/2013 8:19:16 AM : Outperform Start Price: $23.76 BRLI Score: -6.16

BRLI is operating in a long-term trend of increasing health care. It's financial results have shown robust growth trajectories over the last few years. I do not see any reason for this trend to change.

Recs

0
Member Avatar Mathman6577 (21.07) Submitted: 11/19/2012 12:07:29 PM : Outperform Start Price: $25.63 BRLI Score: -31.34

Growth rates > 20%, no debt, lots of cash.

Recs

0
Member Avatar rodessa (22.85) Submitted: 1/17/2012 7:15:35 AM : Underperform Start Price: $17.41 BRLI Score: -12.56

Bad marketing & commercial practices giving less good financial results !

Recs

0
Member Avatar Ellumus (67.85) Submitted: 12/14/2011 5:47:43 PM : Outperform Start Price: $15.60 BRLI Score: +23.08

Bought the stock around $14 wish I found out about it earlier. Strong earnings in a weak economy, great growth stock.

Recs

0
Member Avatar CRad198 (63.45) Submitted: 12/9/2011 3:28:35 PM : Outperform Start Price: $14.08 BRLI Score: +47.14

I wish I entered this yesterday...very high growth, over 20% ROE. It's a growth stock, but its P/E is 2/3 of LabCorp's and only about half of Quest Diagnostics. The reason why it's so low is because some short-selling site alleged shady business practices, shorted the stock, then covered its position within the next few days (apparently constant double digit growth for a $400M market cap company in a giant and rapidly expanding industry is cause for alarm). Short % of float is almost 30%, and they just posted record profits. This opportunity won't last long.

Recs

0
Member Avatar mopoff (< 20) Submitted: 9/2/2011 12:17:14 PM : Outperform Start Price: $20.08 BRLI Score: -24.06

HG

Recs

0
Member Avatar patenmac (< 20) Submitted: 6/2/2011 1:37:32 AM : Outperform Start Price: $21.19 BRLI Score: -20.60

SC QC Limit 21.21

Recs

0
Member Avatar ICTOptimist (< 20) Submitted: 3/26/2011 6:44:32 PM : Outperform Start Price: $22.33 BRLI Score: -22.44

Favorable demographics, smaller company than industry's largest with better growth or acquisition prospects.

Recs

1
Member Avatar debster863 (< 20) Submitted: 3/4/2011 7:22:25 AM : Outperform Start Price: $22.23 BRLI Score: -19.81

I work in Healthcare, this lab has just come into our organization, we currently use labcorp and quest. I started researching bio-referance and it seems a strong company. lots of positives (growth, gendx, cancer research etc). still researching but may grab some today.

Recs

2
Member Avatar bo4fool (40.45) Submitted: 1/6/2011 12:43:38 PM : Outperform Start Price: $23.06 BRLI Score: -31.62

gene testing and other niche tests coming into demand

Recs

0
Member Avatar williamscaps (< 20) Submitted: 9/20/2010 11:50:43 AM : Underperform Start Price: $22.99 BRLI Score: +41.92

22.97

Recs

0
Member Avatar BuffetsMentor (23.09) Submitted: 4/7/2010 9:53:59 PM : Outperform Start Price: $22.02 BRLI Score: -38.27

stock split, and healthcare

Recs

0
Member Avatar mdmardim (< 20) Submitted: 3/4/2010 8:59:18 PM : Outperform Start Price: $21.62 BRLI Score: -42.67

People are always having tests done so a company like this is a cash cow. It could be a takeover candidate for Quest or maybe Mr. Buffet may feel warm blooded and buy this body fluid testing company.

Recs

0
Member Avatar cfackler (94.95) Submitted: 1/8/2010 9:27:10 AM : Outperform Start Price: $19.37 BRLI Score: -26.26

This pick based solely on passage of the healthcare bill. Bill passes, millions of new tests will be ordered and this company will most likely prosper; no healthcare bill, business as usual and this company will still do just fine. (Based on the performance and numbers I've seen to date...)

Results 1 - 20 of 37 : 1 2 Next »

Featured Broker Partners


Advertisement